• Sector: Technology
  • Geography: Europe
  • Stage: Late
  • Investment Year: 2006
  • Exit Year: 2009
  • Website Link

easycash

In 2006, Warburg Pincus invested in easycash, one of Germany’s largest payment acceptance and merchant acquiring companies, which was founded following a carve-out of easycash from its parent, First Data Corporation. Warburg Pincus’ investment thesis was that Germany was one of the most promising payment markets in Europe in terms of growth potential, and easycash would benefit from both internal and external growth in the country. easycash was the first non-bank to be granted full payment acceptance and acquiring licenses in Europe. Warburg Pincus helped easycash consolidate Germany’s fragmented payment landscape with six acquisitions in three years, including both Worldpay and Experian’s German payment businesses. easycash invested heavily in its own payment platform and product offering, doubling the company’s revenues and headcount during Warburg Pincus’ ownership. In 2009, Warburg Pincus and management sold easycash to Ingenico.

Website Case Studies Disclaimer

The investments described in the case studies are provided for illustrative purposes only and are not, and do not purport to be, representative of all investments, or all types of investments, previously made by Warburg Pincus, or indicative of the performance of all prior Warburg Pincus investments. The case studies have been selected on the basis of objective criteria that Warburg Pincus believes are representative of the firm’s experience partnering with portfolio company management teams, and of the sectors, stages, strategies and/or geographies in which the firm invests. The information provided in the case studies are not necessarily an indication of future results, and may not be relied up for any purpose. Warburg Pincus’ current or future portfolio companies may differ materially in size, type, performance and other characteristics from the investments presented in the case studies. Further, references in this case study should not be construed as a recommendation or offer to buy or sell any particular security or to make any particular investment.